Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

Clinic Consulting ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2017 2017/12 2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023e N/A 2024e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 0.5%   Bankruptcy risk   8.9% 13.6% 11.1% 18.4% 12.5% 19.7% 21.2% 19.2%   Credit score (0-100)   30 18 23 7 17 5 4 7   Credit rating   BB BB BB B BB B B B   Credit limit (kDKK)   0.0 -0.0 0.0 0.0 0.0 0.0 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2017 2017/12 2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023e N/A 2024e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   -47.6 -171 120 382 170 -5.8 0.0 0.0   EBITDA   -33.4 -180 120 382 170 -5.8 0.0 0.0   EBIT   -195 -228 120 382 170 -5.8 0.0 0.0   Pre-tax profit (PTP)   -209.3 -251.6 140.1 398.7 168.1 -7.2 0.0 0.0   Net earnings   -166.0 -196.2 69.0 311.0 133.2 -7.2 0.0 0.0   Pre-tax profit without non-rec. items   -209 -252 140 399 168 -7.2 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2017 2017/12 2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023e N/A 2024e N/A Tangible assets total   564 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Shareholders equity total   73.8 -122 -53.4 258 278 70.7 20.6 20.6   Interest-bearing liabilities   784 861 511 10.4 0.0 0.0 0.0 0.0   Balance sheet total (assets)   870 739 458 358 320 70.7 20.6 20.6   Net Debt   710 838 503 4.6 -236 -42.7 -20.6 -20.6     See the entire balance sheet 1000.0 Volume  2017 2017/12 2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023e N/A 2024e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   -47.6 -171 120 382 170 -5.8 0.0 0.0   Gross profit growth   0.0% -259.0% 0.0% 218.1% -55.6% 0.0% 0.0% 0.0%   Employees   0 0 0 0 0 0 0 0   Employee growth %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   870 739 458 358 320 71 21 21   Balance sheet change%   -17.6% -15.1% -38.0% -21.8% -10.6% -77.9% -70.9% 0.0%   Added value   -33.4 -179.8 120.1 382.1 169.6 -5.8 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   -306 -632 0 0 0 0 0 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   -1.0 -2.0 1.0 2.0 3.0 -1.0 0.0 0.0   1000.0 Profitability  2017 2017/12 2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023e N/A 2024e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   410.8% 133.7% 100.0% 100.0% 100.0% 100.0% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   -20.3% -26.4% 20.4% 91.7% 50.0% -2.9% 0.0% 0.0%   ROI %   -21.1% -26.4% 20.4% 102.3% 62.2% -3.3% 0.0% 0.0%   ROE %   -105.9% -48.3% 11.5% 86.9% 49.8% -4.1% 0.0% 0.0%   1000.0 Solidity  2017 2017/12 2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023e N/A 2024e N/A Equity ratio %   8.5% -14.2% -10.4% 71.9% 86.8% 100.0% 100.0% 100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   -2,126.1% -465.9% 418.9% 1.2% -139.3% 740.9% 0.0% 0.0%   Gearing %   1,062.1% -703.7% -958.0% 4.0% 0.0% 0.0% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   1.8% 2.8% 0.0% 0.0% 29.6% 0.0% 0.0% 0.0%   1000.0 Liquidity  2017 2017/12 2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023e N/A 2024e N/A Quick Ratio   0.2 0.9 0.9 3.6 7.6 0.0 0.0 0.0   Current Ratio   0.2 0.9 0.9 3.6 7.6 0.0 0.0 0.0   Cash and cash equivalent   73.6 23.8 8.2 5.8 236.3 42.7 0.0 0.0   1000.0 Capital use efficiency  2017 2017/12 2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023e N/A 2024e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   -662.6 -122.4 -53.4 257.6 277.8 70.7 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2017 2017/12 2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023e N/A 2024e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   0 0 0 0 0 0 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   0 0 0 0 0 0 0 0   EBIT / employee   0 0 0 0 0 0 0 0   Net earnings / employee   0 0 0 0 0 0 0 0